Professor Lietzan Quoted on “Right to Try” Legislation

Professor Erika Lietzan was recently quoted in numerous papers around the country in connection with possible federal “right to try” legislation.

Broadly speaking, the purpose of state “right to try” laws is to make it possible for terminally ill patients to receive unapproved drugs for treatment, if those drugs are currently in clinical trials and certain other conditions are met. One federal proposal under discussion would require the U.S. Food & Drug Administration (FDA) to permit this “compassionate use” treatment in accordance with state law. The agency already permits nearly every request for compassionate use, but Professor Lietzan noted that one complication has always been how to collect and interpret the data about these patients and their outcomes in the eventual application for FDA approval.

Read more via the Ventura County Star, Herald and News, and the Portland Press Herald.